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In 8 patients with psoriasis vulgaris, the cutaneous 
blood flow (CBF) was measured simultaneously in both 
involved and uninvolved psoriatic skin before (i.e., on 
the first day of hospitalization) and on the 3rd, 7th, 
14th, and 28th days of treatment with tar . The 1 '1'1Xe 
washout method was used after epicutaneous labeling 
and compared to the laser Doppler velocimetry (LDV) 
technique. Control experiments were performed in 10 
normal individuals. 
Before treatment the mean CBF in involved psoriatic 
skin was 62.6 ± 18.7 SD ml · (100 g · min) - 1, which is 
significantly higher than CBF of uninvolved skin in 
psoriatic patients, 9 .5 ± 4 .0 SD ml . (100 g . min)- 1 , (p 
< 0.01) and is 13 .6 times higher than CBF in the normal 
individuals (p < 0.01). Fifty hours following onset of 
treatment (i.e., after only 2 applications of tar), mean 
CBF of the involved psoriatic skin had decreased signif-
icantly to 35.0 ± 13 .9 SD ml · (100 g · min)- 1 , (p < 
0.01), which was not statistically different from the CBF 
on the 7th day . During the following weeks, the CBF in 
involved psoriatic skin decreased at a more moderate 
rate than that observed during the first week and was 
15.0 ± 6.1 SD ml · (100 g · min)- 1 on the 28th day. This 
value is not significantly different from the CBF of 
uninvolved skin in these patients. At the end of treat-
ment, the CBF of the uninvolved skin had decreased 
significantly (p < 0.05) in all the patients to values 
similar to those observed in the skin of normal individ-
uals . A parallel decline was observed in a clinical pso-
riatic score index ; however, it is not known whether the 
observed decrease in CBF was preceded or succeeded by 
the clinical improvement. 
A comparison of the "1"Xe measurements and LDV 
measurements in the normal individuals by linear 
regression analysis yielded a correlation coefficient of 
-0.24 (N= 20,p > 0.05). In the skin of psoriatic patients 
the correlation coefficient was 0.01, (N = 47, p > 0 .05) 
for unaffected skin, and 0.61 (N = 47, p < 0.001) in the 
involved psoriatic skin sites. The LDV measurements 
did not reflect changes in the uninvolved skin in pso-
riatic patients during treatment and resulted in a re-
markably high C.V. in the bilateral measurements of 
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Abbreviati ons: 
CBF: cuta neous bl ood fl ow 
CBF,.~, : cutnneous blood fl ow in invo lved pso riatic skin 
CBF""'"'"': cutaneous blood fl ow in uninvolved skin in pso ri atic 
pat ients 
LOY: lase r Doppler velocimetry 
>-c: t issue- to-blood pa rtition coe f'fi cient 
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skin in normal individuals (4 3 .8 %) compared to the C .V. 
of 13:1Xe flow measurements (14.8 %). 
It is concluded that while the LDV method gives a 
rough estimate of blood flow in cutaneous tissue with a 
high capillary perfusion rate, inaccurate m easure m e nts 
are made in skin areas with normal to twice the normal 
CBF range. 
The cuta neou s blood fl ow (CBF) in unt reated pso riat ic le-
s ional s kin is a bout 10 t imes higher t ha n t he no rm a l CBF. In 
uninvolved s kin in pso riatic patients t he CB F is approx imately 
twice as high as it is in no rma l individua ls [1]. 
During a ntipsoriatic t reatmen t and psoriatic improvem en t, 
the abnorma l morpho logy o f psoriatic capill a ries returns to 
norma l as desc ribed by B ra ve rma n a nd S ibley [2]. This t ra n s-
format io n begins 24- 7:2 h a fte r ini t ia t ion of t he a n t ipsoriatic 
t he rapy a nd precedes both t he clinical improveme n t and t he 
decrease in labe ling index o f basa l (germinative ) ce ll laye rs by 
3-8 days [2]. 
M easure ments of C BF in involved a nd uninvolved psoriatic 
skin during a ntipsoria tic t reatme nt have not previous ly been 
publi s hed. 
During t he last few years a new method , lase r Dopple r 
veloc imetry, (LDV) has been introduced using t he p rinciple of 
Doppler -shifted cha nges in refl ection o f laser light from m ov ing 
b lood cells in the cuta neous t issue as a pa ra mete r to estimate 
C BF. 
In t his study t he "1:1X e washout method was used as refe re nce 
method fo r qua ntitative measuremen t of CBF a nd t hese resul ts 
we re compa red to the LDV measureme n ts. P revio us repo rts 
have cla imed that the re is a n excelle nt corre lation b etween t he 
1
:
13Xe was hout method a nd LOY measurements [3-5 ]. H owever 
these prev ious results were based on relatively few experiment~ 
in a s ma ll numbe r o f patie nts. Furthermo re, objection s migh t 
be raised wi t h regard to t he methodology employed in t hese 
inves t igations. 
The purpose o f t he presen t investigation was (1 ) to m easure 
cha nges in C BF in involved a nd uninvolved psoriatic s kin 
during antipso riatic treatmen t using 1'1aX e was hout method for 
quant ita tive measurements of CBF, a nd (2) to compa re t he 
'a3X e method to t he LD V method. 
MATERIALS AND METHODS 
Patients and Control S ubjects 
Eight of nine consecutively admi tted patient s were investigated after 
having given their informed consent . They had typica lly unt reated 
psoriatic plaques on the crus that were more than 10 em in diameter 
and they had normal skin at the cont ralateral site. Pat ients who had 
received topica l treatment with glucocort ico ids, anthra lins, or ta r 
within 1 wee k prior to t he first day of t he study and pat ient.s who had 
received phototherapy wi thin the 3 months prior to the st.udy were 
excluded from the investigation. The nin th patient was excluded after 
the first day of study because she could not lie still dur ing the meas-
urement due to "restless legs." Age, sex, and psoriatic c linical sco re 
index of the patients are shown in T able I. Cont rol experiments were 
performed in 10 hea lthy normal voluntee rs (see Table 4). 
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TABLE I. Clinical psoriatic index before and during t reatment 
Patient Sex A~c Day - I Day :t Day 7 Day 14 Day 2 1 Day 28 
M 25 7 6 3 2 2 
2 F l.'i 6 4 3 2 3 1 
:l M 18 8 6 4 2 2 2 
4 r I G 5 4 4 :l 2 2 
5 F 4:1 7 5 4 3 3 2 
6 r 26 8 7 5 6 :l 1 
7 r :17 8 7 6 5 :l 3 
8 F 2'3 7 4 4 1 1 Discharged 
Mea n 25 7.0 .).4 4.1 3.0 2.4 1.7 
± I SO JO l.l .1.3 1.0 1.7 0.7 0.8 
L____J L_____j L____J !___._1 l-1 
p< 0.0 1 0.05 NS NS NS 
Cutaneous Hlood Flow Measurements 
"'"Xe washout met/we/: The atraumat.ic epicuta neous '"'Xe labeling 
tec hnique was used 11]. A Myla r membra ne was not used s ince control 
experiment s in patients wit h pso rias is showed t ha t retrograde diffusion 
of the trace r throu1(h 1 rea ted o r untrea ted diseased skin was not 
impo rt a nt for measurement of the reco rded washout rate. These control 
experiment s we re pe rformed by comparing measureme nts of t he wash-
out rat e consta nt s dur ing the first 10 min a fte r repeated ep icuta neous 
tracer labeling oft he same skin a rea with a nd without a Mylar mem-
bran e. The findin gs a re co ns ist ent with p revious publica tions by 
Sejrsen 16 1. 
The washout of l he ""'Xe was followed s imulta neous ly at I he bilate ral 
s ites fo r at least 70 min us ing 2 Na l sc intillation detecto rs. A 4 rnm -
thick lead shield was pl aced betwee n t he legs of each pa tient to ensure 
that each sc intillation detector measured the d isappea rance of only one 
trace r depot. Fo r unin vo lved psoriat ic sk in a nd norma l skin, a tissue-
to- bl ood pa rtition coe rti cient (,\c) of 0.7 rnl /g was used in the calcula-
1 ions. The va lues of >-., we re ass igned as follows according to the clinica l 
sco re index: for sco re index va lues from 9- 5 (i.e., severe to moderate 
pso riat ic skin a lte rna tions),"'·"'"'= 1.2 ml/g IlL fo r score index va lues 
from 4- 2, ,\,. va lue = 1.00 ml /g; and for sco re indexes o f I a nd 0, ,\, 
va lue= 0. 7 ml /g. 
""'Xe washout measureme nts we re performed on both sides o f the 
crus in 10 normal indi vidual s in order to exa mine the in t rapersona l 
var ia tion of simult a neous "'"Xe washout measure ments and to measure 
norma l CBF on l he c rus. 
Laser /Joppler/l'clocimelry method: A lase r Doppler fl owmeter (Per-
iflu x, Pe rimed K B, Swede n) was used. The principle of t his instrument 
has bee n expla in ed j f:>j. The instrument reads t he CB F in arbitrary 
un it s of vo lts (a.u.). The results we re ex pressed as the mea n ± SO of 5 
measurements wit hin the skin a rea used to measure ""Xe washout 
immedia tely before the trace r washout measu reme nt s . 
Clinica l Psoriatic S core Index 
Prior to the in vesti ~a tion , clinica l assessment of t he infiltration , 
sca ling, and e rythema o f I he pso riati c pl aques was performed for each 
pat ien l . Each oft hesc pa ra mete rs was graded on n sco re of 0 to 3 with 
zero co rrespondin g to absence of pso ri as is, and 3 bein g t he most severe 
mani festal ions oft he disease 17]. The clinical pso riati c score index was 
calcu lat ed as the sum of l bese :3 grades a nd can be seen in Table I. 
Exprrimentall'rrx'('(/ure 
All patie nt s we re treated according to our sta nda rd procedure, i.e., 
a fte r an oil -in -wa ter morning bath, a so lu tion of beech tar in 50% 
alcohol was a pp lied t.o t he psori at ic s kin les ions . The uninvolved 
pso riatic skin was not protected from the ta r. In the a fte rnoon a nd in 
th e evening topical treatme nt. with 5 'Y,  sa licyl ointment was performed. 
After t,he pso riatic sca li ng disappeared , a bla nd moisturizing cream was 
used twice da ily. One patient (No 8) was di sc ha rged from the depart-
ment on t he 22 nd clay. Th e othe r patie nt s we re dismissed during the 
5th wee k of hospita li za tion. The first measurement was performed 
be fore the 1 reatment started (i .e. , the first. day of hospitalization ). The 
next measureme nt was pe rformed approximately 50 h a fter trea tment 
was in itiated . The follow ing measurements were performed 7, 14 , 21, 
a nd 28 days a fte r t he t rea tmen t was sta rted. Each patient was examined 
at approximate ly the same t ime of day and a fte r 30 min of rest. The 
patie nts we re lying in the supine pos ition a nd at a constant room 
temperature of 20- 21 °C. 
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Statistics 
Analys is o f va riance, t he Wi lcoxon ra nk sum test for pa ired samples, 
the Mann -Whitney rank sum test for unpaired samples, and linear 
correlation us ing the least squares method were used to a na lyze the 
data. p- Values less than 0.05 a re conside red to be s ignificant. 
RESULTS 
Clinical Effects of the Antipsoriatic Treatment 
The clinical psoriatic indices for the 8 patients before and 
during treatment are shown in Table I. 
The improvement in the psoriatic sco re index during the first 
7 days was main ly due to a rapid disappearance of scaling and 
to less infiltration. At the end of the t reatment period, the 
mean score index reflected a faint reddening in all t he patients 
and a persisting moderate infi ltration for patient No 7. 
'
3
"Xe Washout Measurements 
Involved psoriatic skin: The CBF values for patients before 
and during treatment a re shown in Table II. 
Before onset of treatment, the CBF of the involved patient 
skin , CBF,""" was 6.6 times higher than CBF in the contra-
lateral, uninvolved skin in the patients, p < 0.01 , and 13.6 
times higher than CBF of the normal subjects, p < 0.01. 
At t he end of treatment, t he mean CBF,)S0 , was a lmost twice 
as high as t he mean CBF in the symmetrically uninvolved skin , 
but t his difference is not statistically sign ificant (N = 7, p > 
0.05). 
Uninvolved skin in psoriatic patients: Before onset of treat-
ment, t he CBF of the uninvolved patient skin , CBFunpso" was 
twi ce as high as CBF in the normal individua ls, p < 0.01. A 
statistically s ignificant decrease of about 11% in t he CBFunpso' 
was obse rved in a ll patien ts between initiation and cessation 
of treatment as can be seen in Table III . The CBFunpso' at t he 
end of treatment was, however, still s ignificantly higher t han 
t he CBF in the normal individuals, p < 0.01. 
Normal individuals: The CBF values for 10 normal individ-
uals a re shown in Table IV . The C.V. for cont ralateral meas-
urements was 14.8%. 
In t he individual the deviat ion from t he mean of t he contra-
lateral measurements was from 1.6- 23.9% (mean 12.0% + 8.0 
C.V.). 
Laser Doppler Velocimetry Measu.rments 
Involved psoriatic shin: The mean LDV flow in involved 
psoriat ic skin prior to treatment was 11.3 times higher t han 
that found in normal individuals, p < 0.01 , a nd 12.8 times 
higher t han t he flow measurements in uninvolved psoriatic 
ski n, p < 0.01. 
Two days after ini tiation of treatment, the LDV flow in-
creased 23% and 19% in 2 patients (Nos 5 and 7, respectively) , 
while a decrease was observed in the other 6 patients. On the 
th ird day, the mean LDV f1ow was 33.4 ± 13.3, wh ich was not 
statistically significant from t he pretreatment value, 50± 15.8, 
(p < 0.05). On the 7th day, the mean LDV flow was 27.6 ± 
14.4. This was significant ly lower t han t he mean pretreatment 
LDV flow (p < 0.01). 
There was no statistical difference between LDV measure-
ments on days 7 and 14, 23.8 ± 8.5 (p > 0.05). 
The LDV !low was significantly lower on day 21, 13.8 ± 6.5, 
(p < 0.01) compared to measurements on day 14. Between days 
21 and 28 (8.3 ± 3.1, N = 7) there was no statistically s ignificant 
difference (p > 0.05) . 
The LDV !low values in psoriatic skin on day 28 of treatment 
were twice the fl ow values measured in uninvolved skin in 
psoriatic patients as can be seen in Fig 1. This difference is 
statistically s igni fi cant, p < 0.01. 
Uninvolved shin 1:n psoriatic patients: The mean LDV flow 
remained constant (3.9 ± 1.7 before t reatment vs 4.0 + 1.3 after 
t reatment) during treatment as can be seen in Fig 1. 
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TABLE II. Involved psoriatic shin: "'1Xe washout method: cutaneous blood flow (CBF), m.l · (100 g · minr 1 ± SD 
Pat ient 
2 
:3 
4 
5 
6 
7 
8 
Mea n 
± I SO 
p< 
Day - I Day 3 
37.9 ± 1.~ 33.0 ± 0.6 
45.7 ± 0.8 19.6 ± 0.:2 
61.2 ± :L5 37.4 ± 1. 2 
56.:2 ± 0.6 32 .5 ± 0.6 
92 .8 ± 4 - ~~ 44.0 ± 1.3 
56.8 ± 1.4 52.3 ± 0.6 
63.8 ± 1.7 49 .3 ± 3.1 
86.:2 ± 5.:2 12.2 ± 0.2 
62.6 :15.0 
18.7 13.9 
IL..__.:::._:O·.:::..:O 1::..______.~1 I N s 
I om 
0.05 
Day 7 
24.7 ± 0.2 
2 1.2 ± 0.4 
49.9 ± 1.1 
43.7 ± 0.7 
22.9 ± 0.7 
27.0 ± 0. 1 
59.9 ± 0.7 
22 .3 ± 0.4 
34 .0 
15.0 
I I NS 
I 
0.01 
0.05 
Day 14 
20.0 ± 0.4 
23.7 ± 0.2 
22.2 ± 0.5 
30.5 ± 0.4 
29.0 ± 0.3 
24.4 ± 0.4 
67.:2 ± 0.8 
7.1 ± 0.1 
28.0 
17.4 
1 1 o.o5 
Day 21 
15.4 ± 0.3 
20.3 ± 0. 1 
15.9 ± 0. 1 
27.6 ± 0.3 
27.3 ± 0.2 
15.5 ± 0.4 
33.6 ± 0.4 
8.3 ± 0.1 
20.5 
8.4 
1 1 o.o5 
Day 28 
10.3 ± 0.1 
10.1 ± 0.2 
10.8 ± 0.2 
18.1 ± 0.2 
20.9 ± 0.3 
10.1±0.1 
24 .7 ± 0.5 
Discharged 
15.0 
6.1 
I 
TABLE I I I. Unin volved psuriatic shin: 1'1'1Xe washout method: cutaneous blood (lou : (CBF). ml . (100 g · minr 1 ± SD 
Patie nt 
2 
:3 
4 
5 
6 
7 
8 
Mea n 
± 1 so 
Day - J 
18.8 ± 0.6 
9.7 ± 0.3 
6.7 ± 0.1 
7.0 ± 0.4 
10.:2 ± 0.4 
8.8 ± 0.2 
9.0 ± 0.4 
6.0 ± 0.1 
9.5 
4.0 
I NS 
Day 3 
17.6±1.1 
10.6 ± 0.4 
8.9 ± 0.1 
5.5 ± 0.3 
7.0 ± 0.2 
8 .3 ± 0.3 
8.9 ± 0.6 
5.4 ± 0.4 
9.0 
3.9 
I I NS 
NS 
NS 
TABL E IV. Normal individuals: symmetric 1'uXe measurements iCBF 
± 1 SD. ml. (100 g · minr 1J and laser Doppler uelocimctry 
measurements (LD V. arbitrary units± I SD) 
Hight Left 
---
~-
Sex AJ::e 
CBF ± I SD LOY flow CBF ± 1 SD LOY flow 
± I SD ± I SD 
----~ 
1 F 20 5.1 ± 0.:2 4.6 ± o .. s 6.0 ± 0.2 4.0 ± 2.8 
2 M 26 :3.4 ± 0. 1 4.7 ± 2.8 :3.8 ± 0.:2 5.0 ± 2.2 
3 M 27 3.4 ± 0.1 5.4 ± :2 .4 3.5 ± 0.2 5.9 ± 1.7 
4 F 27 4.2±0.1 4.8 ± 2.8 5.0 ± 0.1 4.5 ± 2.5 
5 F 26 5.7 ± 0.1 7.4 ± 2.7 6.2 ± 0.1 3.6 ± 1.3 
6 M 29 5.3 ± 0. 1 5.1 ± 3.1 4.1 ± 0. 1 6.4 ± 4.4 
7 F 22 5.5 ± 0.3 2.2 ± 0.5 4.8 ± 0.2 3.2 ± 1.8 
8 F 25 4.4 ± 0.3 3.2 ± :3.9 4.3 ± 0. 1 2.0 ± 0.:2 
9 M 24 5.3 ± 0.1 1.9 ± 1.0 4.2 ± 0.2 :2.8 ± 1.1 
10 M 2:3 4.3 ± 0. 1 7.2 ± :1.0 4.2 ± 0. 1 4.5 ± 2.:2 
Mean 2!1 4.7 ± 0.2 4.7 ± 2.5 4.6 ± 0.2 4.2 ± 2.3 
± 1 so :3 0.8 1.8 0.9 1.4 
p 
NS 
NS 
r -0.1 7 I -0.35 
i -0.23 I 
No statistica l difference could be demonstrated between f1 ow 
va lues in uninvolved skin in psoriatic patients and normal skin 
in the control individuals. 
Normal individuals: LDV f1ow measured in normal individ -
uals is shown in Table IV. 
Day 7 Day 14 Day 21 Day 28 
18.8 ± 1.1 2 1.5 ± 1.4 16.0 ± 0.8 15.3 ± 1.8 
8.8 ± 0.4 10.8 ± 0.4 8.1 ± 0.1 8.5 ± 0. 1 
10.1 ± 0.1 9.9 ± 0.1 10.4 ± 0.1 6.4 ± 0.1 
7.3 ± 0.2 8.1 ± 0.2 6.4 ± 0.4 6.5 ± 0.1 
6.0 ± 0.2 7.0 ± 0.1 6.4 ± 0.5 7.3 ± 0.2 
6.7 ± 0. 1 6.2 ± 0. 1 7.6 ± 0.1 8.5 ± 0.1 
8.4 ± 0.6 9.6 ± 0.4 8.1 ± 0.6 6.7 ± 0.2 
6.7 ± 0.4 6.4 ± 0.3 4.7 ± 0.2 Disc harged 
9.1 9.9 8.5 8.5 
4.1 5.0 3.5 3. 1 
I I NS I I NS II NS I 
NS 
0.05 
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The mea n LDV fl ow of a ll 20 measurements was 4.42 ± 1.59 
SD. The C.V. in s ide-to-side measurements was 43.8%, and in 
t he individual subjecLs t he varia tio n from t he mean of t he site-
to-s ite measurements was 6.2- 69.1 % (mean 30.0 + 20.6 C.V.). 
SLaLisLical Comparison of the '""Xe W ashou.L M easurements 
and !.he LD V Measurements 
Covaria nce a nalyses showed a nonlinea r relationship be-
tween t he blood fl ow ra tes (including t he blood !low rates 
expressed on a loga ri t hmic sca le) obta ined by t he ""'Xe washout 
method and t he LDV method in involved a nd uninvolved skin 
in t he individual psoria t ic patienL. Analyses of t he correlat ion 
between t he two methods of measu rement showed higher cor-
rela tio n va lues if '""Xe blood fl ow rates were used rather t han 
t he ""'Xe washout rate constants. 
In linea r regression a nalys is of ' '"'Xe fl ow a nd LDV fl ow in 
psoriatic, invo lved skin (Fig 2) and unin vo lved skin of both 
patients a nd normal indiv iduals (Fig 3), t he only signifi cant 
co rrelat ion coeffi cient found was in t he involved psoriat ic skin 
(r = 0.61, N = 47, p < 0.001) . 
DISCUSSION 
The pha rmaco logic act ion of the convent iona lly used anti-
psoriatic age nts is unknown a nd is presumably different. The 
clinical a ntipso ri atic effect of these vari ous substances on t he 
psoriatic lesions a nd t he histo logic a nd histochemical changes 
during ant ipsori atic treatment are, however, ra t her similar- if 
not ident ica l [7- 10]. 
Durin g antipso riatic treatment, t he ful ly developed, typ ica l, 
hi stopathologic abnormaliti es gradually normali ze [8]. Several 
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studies have shown that both the histologic and histochemical 
normalization is ini t iated within t he first few days of t reatment 
[2,8,9 ,11 ,12) and t hat transformation of t he abnorma l psoriatic 
cap illaries begins within 24- 72 h after the initiation of anti-
psoriatic t herapy [13-15). 
Abnorma l papi llary capilla ries can , however, still be found in 
recent ly healed psoriatic skin [11 ,16] and may persist long after 
total clinical resolution [17- 19). Furthermore, t hey may be 
found in skin t hat has presumably never been involved in 
psoriasis [14,17 ,19] . 
The results of the present study confirm our previous obser-
vations [1] that the CBF in untreated psoriat ic skin is high. 
The significant, initia l dec rease in t he CBF of involved pso riat ic 
skin after just 2 tar t reatments is in acco rdance with t he 
previously reported histologic and histochemical changes dur-
ing t he fi rst few days. No definite conclusion can, however, be 
drawn from t he results as to whether t he concomitant clinical 
improvement is preceded by a dec rease in t he CBF in the 
psoriatic involved skin or vice versa. 
The results presented here clearly demonstrate t hat changes 
in CBF may reflect psoriatic activity. The mechanism of action 
of tar in pso riasis has been subject to discussion for years and 
is probably complex [20] . Since the CBF in involved but not 
uninvolved psoriatic skin was influenced by t he tar t reatment 
during t he first 3 weeks, a systemic vasoconstrictor effect seems 
unlikely. A local vasoconstrictive effect, however, would explain 
the signi!icant dec rease in t he CBF of uninvolved skin observed 
at t he end of treatment since sma ll amounts of tar may be 
rubbed off from treated skin . The dec rease in CBF in uni n-
volved skin fo llowing treatment was still s ignificantly higher 
than t hat found in norma l individuals. 
Compa rat ive studies of CBF measurements using t he 133Xe 
washout method and LDV methods have been reported in only 
a few publications [3-5]. Holloway and Watkins [3] compared 
the two methods in 16 experiments and found a linear regres-
sion coefficient of 0.89 between the two methods. However, in 
t he '""Xe washout measurements, t he CBF was calculated with-
out t he proper graphic cu rve reso lut ion of the 13'1Xe washout 
curve, which leads to an underestimation of the CBF values. 
Furt hermore, the CBF measuremen ts were performed imme-
diately a fter t he injection , which would lead to an ove restima-
t ion of t he CBF due to the trauma of injection. In a later study, 
Holloway has used LDV measu rements to illustrate t his point 
[21 ). Moreover, measurements were performed in skin areas 
that had been traumatized wit h UV radiation, which might 
inf1uence t he t issue-to -blood partition coeffi cient because of 
intradermal edema and thus also influence the CBF values. 
The LDV fl ow va lues were obta ined before traumatizing t he 
skin by t he "1"Xe injection and during the trauma phase . LDV 
values in non-UV -irradiated skin were found to be 81 % higher 
than those obtained before the injection t rauma and were 
excluded from t he data used for regression analysis. Because of 
these considerations, the conclusions draw n by Holloway and 
Watkins must be ta ken with the ut most precaut ion. 
The same experimental procedure was used in another in-
vestigation [4] and should therefore be subject to t he same 
cri t ique. 
Engelhart and Kristensen [5] compared LDV measurements 
and "1"Xe washout measurements using atraumatic tracer la-
beling tec hnique in 4 individuals. They concluded that t here 
are fundamenta l differences between the para meters measured 
by t he two methods, a lthough, in their hands, the laser Doppler 
method did seem capable of measurin g relative changes in CBF. 
In t heir study, the "1'1Xe measurements of the CBF were per-
fo rmed in t he !ingert ips, i.e., a region with abundant subcuta-
neous fat. Since graphic curve resolution of the washout curve 
was not performed , their quali tative measurements of CBF 
must also be considered with precaution. 
In t he present study, the LDV fl ow measurements varied 
considerab ly wi t hin a skin a rea of 10 cm2 , which is ref1ected in 
the high SD (see Table IV) . This high va riation might be 
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attribu ted to t he sma ll measuring fi eld of t he lase r Doppler 
probe (approximate ly 5 mm"), which necessitates measure-
men ts at seve ra l po ints to obta in re li able values from the region 
bein cr tested. T he variation might a lso be due to true fluctua-
t ion; in t he loca l CBF. Howeve r, ' '"'Xe was hout experiments 
using atraumatic labeling of skin a reas ran ging from 20 cm2 to 
Jess t ha n 1 cm 2 have resul ted in monoexponent ia l washout 
curves for a half hour or more [6 ,22]. This findin g strongly 
indicates t hat CBF is re lat ively constant within t he same 
anatomic region under steady state condi t ions. 
The data presented here indicate t hat the LDV method does 
not measure CBF. High local variat ion in LDV fl ows have been 
found, t he laser Doppler apparatus cannot distinguis h between 
CBF in skin from normal individuals and uninvo lved skin in 
psoriatic patients, a nd t here is only a weak correlatio n between 
the J33Xe fl ows a nd LDV fl ows in invo lved psoriatic skin during 
t reatment. T he lase r Doppler method might, however, be used 
to give rough estimates of changes in CBF in involved patient 
s kin during t reatment. 
Aage V0lund, Ph. 0., Jm;titute o f Mathematica l S t atis ti cs, U nive rs ity 
of Copenhagen is gratefully acknowledged for help wit h statis tica l 
analyses of t he data. 
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